Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | nuclear receptor subfamily 3, group C, member 2 | Starlite/ChEMBL | References |
Homo sapiens | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | Starlite/ChEMBL | References |
Homo sapiens | progesterone receptor | Starlite/ChEMBL | References |
Homo sapiens | estrogen receptor 1 | Starlite/ChEMBL | References |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | 0 nM | Displacement of [3H]-mibolerone from human androgen receptor; ND means Not determined | ChEMBL. | 15080982 |
IC50 (functional) | = 430 nM | Effect on human Glucocorticoid receptor (GR) in a whole cell assay to measure functional cellular GR-antagonism (GRAF) | ChEMBL. | 15080982 |
IC50 (functional) | = 430 nM | Effect on human Glucocorticoid receptor (GR) in a whole cell assay to measure functional cellular GR-antagonism (GRAF) | ChEMBL. | 15080982 |
IC50 (binding) | = 454 nM | Displacement of [3H]-aldosterone from human Mineralocorticoid receptor | ChEMBL. | 15080982 |
IC50 (binding) | = 454 nM | Displacement of [3H]-aldosterone from human Mineralocorticoid receptor | ChEMBL. | 15080982 |
IC50 (binding) | = 519 nM | Displacement of [3H]-dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 378-814 nM | ChEMBL. | 15080982 |
IC50 (binding) | = 519 nM | Displacement of [3H]-dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 378-814 nM | ChEMBL. | 15080982 |
IC50 (binding) | = 2281 nM | Displacement of [3H]-estradiol from human estrogen receptor alpha | ChEMBL. | 15080982 |
IC50 (binding) | = 2281 nM | Displacement of [3H]-estradiol from human estrogen receptor alpha | ChEMBL. | 15080982 |
IC50 (binding) | = 10000 nM | Displacemnt of [3H]-progesterone from human Progesterone receptor | ChEMBL. | 15080982 |
IC50 (binding) | = 10000 nM | Displacemnt of [3H]-progesterone from human Progesterone receptor | ChEMBL. | 15080982 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.